Replies to post #107236 on Biotech Values

[genisi]

Tysabri's sales look even weaker considering the 18.7% price hike from early July.

[genisi]

4Q10 Tysabri end user sales - $333M, of which $162 million were in the U.S. and $171 million were in rest of world.

http://finance.yahoo.com/news/CORRECTING-andREPLACING-bw-3184710322.html?x=0&.v=2